Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 14/10/2019
SIETES contiene 92822 citas

 
 
<< anterior 21 a 40 de 71 siguiente >>
Presentar resultados
Seleccionar todas
21.
Anónimo. Understanding statistical terms: 4 - Diagnostic tests. Drug Ther Bull 2009;47:71-2. [Ref.ID 86029]
22. Cita con resumen
Anónimo. TPMT testing before azathioprine therapy?. Drug Ther Bull 2009;47:9-12. [Ref.ID 85020]
23.Tiene citas relacionadas Cita con resumen
Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet 2008;371:923-31. [Ref.ID 82403]
24.Tiene citas relacionadas Cita con resumen
Mendis S, Mohan V. Non-laboratory-based prediction of cardiovascular risk. Lancet 2008;371:878-9. [Ref.ID 82393]
25.Tiene citas relacionadas Cita con resumen
Järvinen TLN, Sievänen H, Khan KM, Heinonen A, Kannus P. Shifting the focus in fracture prevention from osteoporosis to falls. BMJ 2008;336:124-6. [Ref.ID 82021]
26.Enlace a cita original Cita con resumen
Moonesinghe R, Khoury MJ, Cecile A, Janssens JW. Most published research findings are false - But a little replication goes a long way. PLOS Medicine 2007;4:28. [Ref.ID 79264]
27. Cita con resumen
Michel C-EC, Solomon AW, Magbanua JPV, Massae PA, Huang L, Mosha J, West SK, Nadala ECB, Bailey R, Wisniewski C, Mabey D, Lee HH. Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: a comparative study. Lancet 2006;367:1585-90. [Ref.ID 76879]
28. Cita con resumen
Niskanen L K, Llaksonen DE, Nyyssönen K, Alfthan G, Lakka HM, Lakka TA, Salonen JT. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men. A prospective cohort study. Arch Intern Med 2004;164:1546-51. [Ref.ID 71015]
29. Cita con resumen
Tucker G. Pharmacogenetics - expectations and reality. BMJ 2004;329:4-6. [Ref.ID 70615]
30.
Liu J, Hong Y, D'Agostino RB, Wu Z, Wang W, Sun J, Wilson PWF, Kannel WB, Zhao D. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese multi-provincial cohort study. JAMA 2004;291:2591-9. [Ref.ID 70204]
31. Cita con resumen
Sorensen PS, Ross C, Clemmesen KM, Bendtzen K, Frederiksen JL, Jensen K, Kristensen O, Petersen T, Rasmussen S, Ravnborg M, Stenager E, Kock-Henriksen N, and the Danish Multiple Sclerosis Study Group. Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis. Lancet 2003;362:1184-91. [Ref.ID 67810]
32.
van der Meer I M, de Maat MPM, Kiliaan AJ, van der Kuip DAM, Hofman A, Witteman JCM. The value of C-reactive protein in cardiovascular risk prediction. Arch Intern Med 2003;163:1323-8. [Ref.ID 66537]
33.Tiene citas relacionadas Cita con resumen
Sniderman AD, Furberg CD, Roeters van Lennep J E, Jungner I, Walldius G. Lipoproteins and cardiovascular risk. Authors' reply. Lancet 2003;361:1989. [Ref.ID 66185]
34.Tiene citas relacionadas Cita con resumen
Ravnskov U. Lipoproteins and cardiovascular risk. Lancet 2003;361:1988-9. [Ref.ID 66184]
35.Tiene citas relacionadas Cita con resumen
Rosch P J. Lipoproteins and cardiovascular risk. Lancet 2003;361:1988. [Ref.ID 66183]
36. Cita con resumen
Barratt PL, Seymour MT, Stenning SP, Georgiades I, Walker C, Birbeck K, Quirque P, and the UKCCCR AXIS trial collaborators. DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study. Lancet 2002;360:1381-91. [Ref.ID 63912]
37.
ten Wolde M, Kraaijenhagen RA, Prins M H, Büller HR. The clinical usefulness of D-dimer testing in cancer patients with suspected deep venous thrombosis. Arch Intern Med 2002;162:1880-4. [Ref.ID 63389]
38.Tiene citas relacionadas Cita con resumen
Wald NJ, Law M, Haddow JE, Craig WY. Apolipoproteins and prediction of fatal myocardial infarction. Lancet 2002;359:1864. [Ref.ID 62195]
39.Tiene citas relacionadas Cita con resumen
Walldius G, Jungner I, Aastveit A, Holme I. Apolipoproteins and prediction of fatal myocardial infarction. Authors' reply. Lancet 2002;359:1863-4. [Ref.ID 62194]
40.Tiene citas relacionadas Cita con resumen
Wägner AM, Ordóñez-Llanos J. Apolipoproteins and prediction of fatal myocardial infarction. Lancet 2002;359:1863. [Ref.ID 62193]
Seleccionar todas
 
<< anterior 21 a 40 de 71 siguiente >>